HIGH OVERALL RESPONSE RATE WITH THE BTK INHIBITOR BGB‐3111 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA: AN UPDATE ON SAFETY AND ACTIVITY
暂无分享,去创建一个
S. Opat | C. Tam | J. Seymour | J. Trotman | M. Anderson | W. Kim | L. Wang | D. Simpson | D. Ritchie | J. Huang | A. Roberts | G. Cull | S. Ratnasingam | D. Gottlieb | M. Ku | P. Marlton | B. Augustson | L. Xue | J. Hilger | E. Hedrick